[Effective antibacterial therapy in otorhinolaryngology: bacteriological rationale].
The article presents current views on etiopathogenesis of the diseases associated with contamination with microorganisms; reviews inflammatory ENT diseases in terms of current literature on clinical microbiology of these diseases; characterizes microorganisms more or less specific for each relevant nosological entity; analyses basic groups of antibacterial drugs with formulation of bacteriologically grounded principles of initial antibacterial therapy of ENT inflammation.
Zhukhovitskiĭ
V G
VG
D000900:Anti-Bacterial Agents / Q000145:classification* / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000145:classification / Q000188:drug therapy / Q000382:microbiology; D004826:Epiglottitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D038801:International Classification of Diseases; D010032:Otitis Externa / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D010033:Otitis Media / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D010036:Otolaryngology / Q000379:methods*; D010612:Pharyngitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D012141:Respiratory Tract Infections / Q000175:diagnosis* / Q000188:drug therapy*; D012852:Sinusitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D014069:Tonsillitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents